Market Overview

UPDATE: Bank of America Merrill Lynch Initiates Coverage on Mylan with Overweight Rating

Share:
Related MYL
Mylan And Teva Earnings Are Coming: Here's What To Expect
David Einhorn's New Long Position In Mylan
Buy A Bargain Stock With Lannett Near 2-Year Lows (Seeking Alpha)

In a report published Monday, Bank of America Merrill Lynch initiated coverage on Mylan (NASDAQ: MYL) with an Overweight rating.

BofA Merrill Lynch noted, “We initiate coverage on Mylan at OW-100%, as we see material yield and promising long-term growth prospects vs. peers within the IG Pharma subsector. Moody's and S&P upgraded Mylan to investment grade last week mainly due to its strong positioning in the generics market and favorable financial policies.”

Mylan closed on Friday at $27.11.

Latest Ratings for MYL

DateFirmActionFromTo
Dec 2015Goldman SachsUpgradesBuyConviction Buy
Dec 2015Morgan StanleyAssumesEqual-weight
Nov 2015Leerink SwannMaintainsOutperform

View More Analyst Ratings for MYL
View the Latest Analyst Ratings

Posted-In: Bank of America Merrill LynchAnalyst Color Initiation Analyst Ratings

 

Related Articles (MYL)

Get Benzinga's Newsletters